Ulcerative Colitis

... Women's silent health problem: Study finds fecal incontinence is prevalent in US women Public release date: 17-Jan-2006 [ | E-mail Article ] Contact: Katie Gazella kgazella@umich.edu 734-764-2220 University of Michigan Health System Women's silent health problem: Study finds fecal incontinence is prevalent in US women Numbers high among older women, women who have had several babies and women who have major depression It's a topic that is discussed so infrequently – for reasons that are easy to understand – that it may seem it isn't much of a problem.

But new research shows that fecal incontinence is prevalent among U.S.

women, especially those in older age groups, those who have had numerous babies, women whose deliveries were assisted by forceps or vacuum devices, and those who have had a hysterectomy.

Many women in the study who had fecal incontinence also had another medical condition, such as major depression or diabetes, and often experienced urinary incontinence in addition to FI.

The findings are reported in the American Journal of Obstetrics and Gynecology.

"Increased attention should be paid to this debilitating condition, especially considering the aging of our population and the available treatments for FI," says senior author Dee E.

Fenner, M.D., associate professor of obstetrics and gynecology, and director of gynecology, at the University of Michigan Medical School.

"It is very important to the health of women that clinicians are aware of the prevalence of FI...

...Jenkins What takes place with IBD, Crohn’s, and This swelling causes ulcerations and injury to the bowel, as well as various other negative side effects.

Although extensive research has been done, it is unclear what causes the excessive immune response in IBD.

Some believe it is the body’s mistaken identification of good bacteria in the bowel as being dangerous, while others believe it is a foreign agent that triggers the immune system, which in turn, does not shut down properly.

Whatever the reason, this is a chronic condition which will continue to be a problem for sufferers for an extended period of time.

The primary difference between Crohn’s Disease and Crohn’s Disease may affect any portion of the digestive system and may occur in patches, with unaffected areas in between.

However, Crohn’s Disease primarily affects the end of the small intestine and the beginning of the large intestine.

On the other hand, Often, it is very difficult to determine which form of IBD a patient is suffering from and misdiagnosis is common.

Symptoms common of Irritable Bowel Disorder are diarrhea, abdominal pain...

... PharmaLive: Schering-Plough Initiates PEG-INTRON Maintenance Study in Patients Coinfected With Hepatitis C and HIV REGISTERED USERS TODAY ON PHARMALIVE.COM Schering-Plough Initiates PEG-INTRON Maintenance Study in Patients Coinfected With Hepatitis C and HIV ENDURE Study to Assess Low-Dose PEG-INTRON Monotherapy in Helping to Prevent Hepatitis C Disease Progression in Coinfected Patients AMSTERDAM, Netherlands, January 13, 2006 /PRNewswire-FirstCall/ - Schering-Plough announced today that it is initiating a large multinational clinical trial to evaluate the use of low-dose PEG-INTRON(R) (peginterferon alfa-2b) maintenance monotherapy in preventing or delaying hepatitis C disease progression and thus potentially reducing the occurrence of clinical events such as liver transplantation, liver cancer and death in cirrhotic patients with hepatitis C who are coinfected with HIV.

Known as the ENDURE study, the trial is targeted to enroll 448 patients at approximately 80 sites worldwide, including centers in the United States, Europe and Canada.

Approximately one third of HIV patients, or about 10 million people worldwide, are coinfected with the hepatitis C virus (HCV) and HIV.(1) Liver disease caused by chronic hepatitis C is now a leading cause of morbidity and mortality among HIV-infected patients in the developed world.(2,3) Furthermore, studies have shown that HCV can aggravate the course of HIV infection.(4) "The principal goal for treating patients infected with hepatit...